Cite
HARVARD Citation
Wang, D. et al. (2020). Comparing the efficacy and safety of second-line therapies for advanced hepatocellular carcinoma: a network meta-analysis of phase III trials. Therapeutic advances in gastroenterology. p. . [Online].